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Abstract
In the editorial published in this journal, Daniels and colleagues argue that his and Sabin’s accountability for 
reasonableness (A4R) framework should be used to handle ethical issues in the health technology assessment 
(HTA)-process, especially concerning fairness. In contrast to this suggestion, it is argued that such an approach 
risks suffering from the irrrelevance or insufficiency they warn against. This is for a number of reasons: lack of 
comprehensiveness, lack of guidance for how to assess ethical issues within the “black box” of A4R as to issues 
covered, competence and legitimate arguments and finally seemingly accepting consensus as the final verdict on 
ethical issues. We argue that the HTA community is already in a position to move beyond this black box approach.
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In the editorial published in this journal, Daniels and colleagues argue that since societies cannot cover all health interventions, decision-makers face the challenge 
of how to prioritize different health interventions. According 
to the authors such prioritizing should be made on the basis 
of sound evidence. Health technology assessment (HTA) 
might provide such evidence, and generally does when it 
comes to safety, efficacy and cost-effectiveness. However, 
there is more to making an ethically well-founded decision 
on which health interventions to cover and the authors argue 
that HTA should incorporate ethical assessment in general 
and considerations of equity and fairness in particular. Since 
we cannot agree on principles for how to prioritize, Daniels 
and colleagues suggest that accountability for reasonableness 
(A4R) framework should be adopted to achieve both 
legitimate and fair decisions. The appeal to procedural justice 
is made in part on the belief that a fair process secures fair 
outcomes, as the following statement indicates: “…there is 
considerable plausibility to accepting the outcomes of a fair 
process as fair.”1
Even if it could be argued that Daniels et al do not give full 
notice to the fact that ethical assessment has been part of the 
concept of HTA for long and that lately there are a large number 
of ethics initiatives on how to systematically implement 
ethical assessment at different levels of the HTA-process 
within the HTA-community, there is a long way to go before 
this is satisfactory. Moreover, Daniels et al are right in that 
irrelevance is a greater threat for HTA than is overreaching. 
With irrelevance they seem to mean insufficiency, rather than 
strictly irrelevance (since the basic considerations of clinical 
effectiveness, safety and cost-effectiveness might still be 
relevant but insufficient) [1]. In the following, we will hence 
use the term insufficiency. The problem seems to be that 
the authors do not go far enough and, the result from their 
suggested approach risks suffering from insufficiency when 
it comes to assessing ethical aspects of health technologies. 
First, ethical aspects cover a larger field than just considerations 
about fairness – including aspects like autonomy, integrity, 
privacy, dignity, etc. If a technology fails to pass the test of 
living up to norms about dignity or autonomy, it does not help 
if it is equitably distributed. The editorial does acknowledge 
that there can be defeating values to the procedural approach 
but fails to suggest which they are or how these ethical 
aspects should be assessed or allowed to defeat the procedural 
approach. 
Second, A4R could be seen as a kind of black box approach to 
ethical issues. You gather a group, set up a set of administrative 
constraints and then, what comes out, should be accepted as 
fair (if having followed the constraints). Even following the 
transparency and publicity criterion, and presenting all the 
considerations openly – it is still a black box approach in 
that there are no substantial ethical guidelines, constraints 
or principles that provides guidance as to how this process 
should take place. Hence, almost anything might turn up at 
the end of the box depending on the group in question. This is 
not very helpful to provide relevant ethical assessment within 
HTA, even if it might give part of the answer, as other authors 
also have pointed to.2 In our experience, having worked with 
ethical issues in HTA for quite a few years – what is needed 
are concrete tools highlighting relevant ethical aspects and 
helping HTA-agencies to provide consistent assessments that 
are not biased by what the assessment groups happen to focus 
on.3-6
Third, the editorial discusses the argument that ethical 
assessment goes beyond the competence of the HTA-agency. 
Surprisingly enough, there is no mentioning of ethics 
competence in this discussion. Making a proper ethical 
analysis, including identifying relevant ethical issues, and 
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implications for fairness, requires competence. As the authors 
should be well aware of, since they are heralded by a highly 
distinguished philosopher, this requires philosophical skills 
and ethical sensitivity. Sorting out conceptual issues, assessing 
the logic and consistency of argumentation, providing insight 
into how the arguments fit into the more general ethical 
discourse etc. Even if we do not argue that philosophers or 
ethicists can provide the final verdict on what ought to be 
done, they can provide a well-analyzed and reasoned account 
of the ethical landscape of the intervention for decision-
makers to take into account (besides the data on safety, 
efficacy, and cost-effectiveness). 
Fourth, decisions concerning coverage in a specific healthcare 
jurisdiction are not made in an ethical vacuum. Most 
healthcare legislations, official guidelines, and established 
practices provide some guidance on how to interpret ethical 
values and norms in that context. 
Fifth, the argument in favor of A4R rests, to a large extent, on 
the problem of achieving consensus. As people have different 
views on how resources should be distributed we cannot 
apply substantive principles of fairness. If the day comes 
when such agreement is reached, we could, according to ND, 
judge “…different result as ‘wrong’ or ‘unfair’….”1 But why 
place such a weight on consensus when it seems quite clear 
that we historically have been able to formulate convincing 
ethical arguments against things like slavery or in favor of 
gender equality – despite lack of consensus. Rather, the ethical 
arguments have precluded and influenced social attitudes. 
Moreover, consensus is a poor guarantee for moral rightness. 
For example, social approval of slavery does not make that 
practice morally right.
In conclusion, we should move beyond the black procedural 
box approach to ethical issues in HTA, filling the box with 
structured frameworks for comprehensiveness concerning 
ethical issues, with skilled ethicists, with established and 
codified interpretations of ethical values and norms. This 
work has already started with a number of good initiatives 
on its way. Unfortunately, the suggestions in the editorial do 
not add much of substance to this development and thereby 
falls in the trap they warn about - insufficiency (or irrelevance 
using their original term).
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Endnotes
[1]  We owe this observation to an anonymous reviewer.
 
References
1. Daniels N, Porteny T, Urritia J. Expanded HTA: Enhancing 
Fairness and Legitimacy. Int J Health Policy Manag. 2015;5(1):1-
3. doi:10.15171/ijhpm.2015.187
2. Biron L, Rumbold B, Faden R. Social value judgments in 
healthcare: a philosophical critique. J Health Organ Manag. 
2012;26(3):317-330. 
3. Hofmann B. Toward a procedure for integrating moral issues 
in health technology assessment. Int J Technol Assess Health 
Care. 2005;21(3):312-318. 
4. Saarni SI, Braunack-Mayer A, Hofmann B, van der Wilt GJ. 
Different methods for ethical analysis in health technology 
assessment: An empirical study. Int J Technol Assess Health 
Care. 2011;27(4):305-312. doi:10.1017/s0266462311000444
5. Duthie K, Bond K. Improving ethics analysis in health technology 
assessment. Int J Technol Assess Health Care. 2011;27(1):64-
70. doi:10.1017/s0266462310001303
6. Heintz E, Lintamo L, Hultcrantz M, et al. Framework for 
systematic identification of ethical aspects of healthcare 
technologies: the SBU approach. Int J Technol Assess Health 
Care. 2015;31(3):124-130. doi:10.1017/s0266462315000264
